Glen Eagle Advisors, LLC Amgen Inc Transaction History
Glen Eagle Advisors, LLC
- $527 Billion
- Q1 2024
A detailed history of Glen Eagle Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 1,851 shares of AMGN stock, worth $621,214. This represents 0.1% of its overall portfolio holdings.
Number of Shares
1,851Holding current value
$621,214% of portfolio
0.1%Shares
1 transactions
Others Institutions Holding AMGN
# of Institutions
2,970Shares Held
401MCall Options Held
6.59MPut Options Held
6.61M-
Vanguard Group Inc Valley Forge, PA52.1MShares$17.5 Billion0.3% of portfolio
-
Black Rock Inc. New York, NY48MShares$16.1 Billion0.32% of portfolio
-
State Street Corp Boston, MA29.1MShares$9.78 Billion0.38% of portfolio
-
Primecap Management CO Pasadena, CA14.6MShares$4.9 Billion3.15% of portfolio
-
Morgan Stanley New York, NY14MShares$4.69 Billion0.32% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $180B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...